期刊文献+

睾酮对慢性心力衰竭雄性大鼠左心功能的影响

Effect of physiological dose testosterone on left ventricular function of male rats with chronic heart failure
下载PDF
导出
摘要 目的:观察生理剂量睾酮(Testosterone,T)替代治疗对心力衰竭雄鼠左心功能的影响。方法:健康雄性SD大鼠120只,随机分为假术组(sham组,n=15),模型组(n=105)。模型组行冠脉结扎术,术后6周模型组存活44只,随机分为治疗组(CHF+TU,n=22)、心衰对照组(CHF,n=22),治疗组给予十一酸睾酮(testosterone undecanonate TU)5 mg/kg/次,1次/2周深部肌肉注射。心衰对照组给等容积的灭菌花生油。给药前、睾酮治疗12周后分别行超声学检查以评价心功能。结果:心力衰竭大鼠T水平与Sham组比较明显降低(179.3±89.81 ng/dl vs.475.28±161.37 ng/dl,P<0.05),TU治疗12周后CHF+TU组大鼠左室射血分数(EF)与CHF组比较明显改善(36.1±9.3%vs.33.2±7.5%,P<0.05)。结论:雄性慢性心力衰竭大鼠T水平明显降低,生理剂量的T替代治疗可以改善心衰大鼠左心功能。 Objective: To investigate the effects of physiological dose testosterone undecanonate(TU) on the left ventricular function of male rats with heart failure after myocardial infarction. Methods : 120 SD male rats were randomly assigned to ligation of coronary artery ( n = 105) or sham operation (sham, n = 15). 6 weeks later , 44 survived model rats were randomly divided into 2 groups: CHF + TU group ( n = 22) treated with TU 5 mg/kg per 2 weeks intramuscular injection; CHF group( n = 22) treated with placebo. Serum testosterone levels were determined after treatment for 12 weeks. The left ventricular functions were examined by echocardiography. Results : In CHF male rats EF of left ventficular compared with the Sham group were greatly decreased(33.2 ± 7.5% vs.69.1 ± 6.7%, P 〈 0.05) companying with the decrease of serum testosterone level( 179.3 ± 89.81 ng/dl vs. 475.28 ± 161.37 ng/dl, P 〈 0. 05). After physiological dose TU administration the EF of the CHF + TU group rats improved significantly compared with its of the sham group rats (36.1 ± 9.3 % vs. 33.2 ± 7.5 %, P 〈 0.05).Conclusion : The serum level testosterone of male rats with heart failure after myocardial infarction was decreased significantly. Physiological dose testosterone treatment can improve left ventricular systolic function.
出处 《河南医学研究》 CAS 2006年第1期16-18,共3页 Henan Medical Research
基金 河南省普通攻关基金资助项目(编号:0324410132)
关键词 心力衰竭 睾酮 超声心动图 heart failure testosterone echocardiography
  • 相关文献

参考文献12

  • 1KontoleonPE,Anastasiou-Nana MI,Papapetrou PD,et al.Hormonal profile in patients with congestive heart failure [ J].Int J Cardiol,2003,87(3):179-183.
  • 2Anker SD,Chua TP,Ponikowski P,et al.Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia[J].Circulation,1997,96(2):526-534.
  • 3陈倩,李小鹰,李江源,张万义,李洪涛,刘芳.老年男性心力衰竭患者性激素水平调查及与同龄健康男性的比较[J].中华心血管病杂志,2005,33(6):505-508. 被引量:34
  • 4English KM,Jones RD,Jones TH,et al.Testosterone acts as a coronary vasodilator by a calcium antagonistic action [ J ].J Endocrinol Invest,2002,25 (5):455-458.
  • 5Pugh PJ,Jones TH,Channer KS.Acute haemodynamic effects of testosterone in men with chronic heart failure[J].Eur Heart J,2003,24(10):909-915.
  • 6Sieminska L,Wojciechowska C,Swietochowska E,et al.Serum free testosterone in men with coronary artery atherosclerosis [ J ].Med Sci Monit,2003,9(5):CR162-166.
  • 7English KM,Steeds RP,Jones TH,et al.Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina:A randomized,double-blind,placebo-controlled study [ J ].Circulation,2000,102(16):1906-1911.
  • 8Pugh PJ,Jones RD,West JN,et al.Testosterone treatment for men with chronic heart failure[J].Heart,2004,90(4):446-447.
  • 9Golden KL,Marsh JD,J iang Y.Castration reduces mRNA levels for calcium regulatory proteins in rat heart [ J ].Endocrine,2002,19 (3):339-344.
  • 10AnkerSD,Ponikowski P,Varney S,et al.Wasting as independent risk factor for mortality in chronic heart failure[J].Lancet,1997,349(9058):1050-1053.

二级参考文献14

  • 1中华医学会老年医学学会对健康老年人标准的建议[J].中华老年医学杂志,1996,9:15-15.
  • 2Peter A,Jens H,Claus C. The relationgship of natural androgens to coronary heart disease in males: a review. Aterosclerosis, 1996,125:1-13.
  • 3Katherine M,Richard PS,Hugh J,et al. Low-dose transdermal testosterone therapy improvesangina threshold in men with chronic stable angina: a randomized, double-blind, placebo-controlled study. Circulation, 2000,102:1906-1911.
  • 4English KM, Strrds R, Jones TH, et al. Testosterone and coronary heart disease:is there a link? Q J Med,1997,90:787-791.
  • 5Phillips GB, Pinkermell BH, Jing TY. The association of hypotestosteronemia with coronary artery disease in men. Arterioscler Thromb, 1994,14:701-706.
  • 6Barrett-Connor E, Khaw KT, Yen SSC. A prospective study of dehydroepiandrosterone sulfate mortality and cardiovascular disease. N Engl J Med,1986,315:1519-1524.
  • 7Anker SD, Chua TP, Ponikowski P, et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation ,1997,96:526-534.
  • 8Noirhomme P, Jaquet L, Underwood M, et al. The effect of chronic mechanical circulatory support on neuroendocrine activation in patients with end-stage heart failure. Eur J Cardiothorac Surg, 1999, 16:63-67.
  • 9Otenweller JE, Tapp WN, Creghton D, et al. Aging, stress and chronic disease interact to suppress plasma testosterone in Syrian hamsters. J Gerontol, 1988,43:175-180.
  • 10Tappler B, Katz M. Pituitary-gonadal dysfunction in low-output cardiac failure. Clin Endocrinol,1979,10:219-226.

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部